Literature DB >> 29269413

β1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells.

Chunhong Cui1, Xiaoning Chen1, Ying Liu1, Benjin Cao1, Yang Xing1, Chanjuan Liu1, Fan Yang1, Yinan Li1, Tianxiao Yang1, Lingyang Hua2, Mi Tian3, Yuanyan Wei4, Ye Gong5,3, Jianhai Jiang6.   

Abstract

Malignant glioblastoma multiforme is one of the most aggressive human cancers, with very low survival rates. Recent studies have reported that glioma stem-like cells transdifferentiate into endothelial cells, indicating a new mechanism for tumor angiogenesis and potentially providing new therapeutic options for glioblastoma treatment. Glioma malignancy is strongly associated with altered expression of N-linked oligosaccharide structures on the cell surface. We have previously reported that β1,4-galactosyltransferase V (β1,4GalTV), which galactosylates the GlcNAcβ1-6Man arm of the branched N-glycans, is highly expressed in glioma and promotes glioma cell growth in vitro and in vivo However, the mechanism by which β1,4GalTV stimulates glioma growth is unknown. Here we demonstrate that short hairpin RNA-mediated β1,4GalTV knockdown inhibits the tumorigenesis of glioma stem-like cells and reduces their transdifferentiation into endothelial cells. We also found that β1,4GalTV overexpression increased glioma stem-like cell transdifferentiation into endothelial cells and that this effect required β1,4GalTV galactosylation activity. Moreover, β1,4GalTV promoted β1,4-galactosylation of Notch1 and increased Notch1 protein levels. Of note, ectopic expression of activated Notch1 rescued the inhibitory effect of β1,4GalTV depletion on glioma stem-like cell transdifferentiation. In summary, our findings indicate that β1,4GalTV stimulates transdifferentiation of glioma stem-like cells into endothelial cells by activating Notch1 signaling. These detailed insights shed important light on the mechanisms regulating glioma angiogenesis.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Notch1; cancer stem cells; differentiation; endothelial cell; glioblastoma; glioma stem-like cell; glycosyltransferase; transdifferentiation; β4GalTV

Mesh:

Substances:

Year:  2017        PMID: 29269413      PMCID: PMC5808780          DOI: 10.1074/jbc.RA117.000682

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Role of glycans and glycosyltransferases in the regulation of Notch signaling.

Authors:  Hamed Jafar-Nejad; Jessica Leonardi; Rodrigo Fernandez-Valdivia
Journal:  Glycobiology       Date:  2010-04-05       Impact factor: 4.313

2.  Notch, a universal arbiter of cell fate decisions.

Authors:  Matthias Ehebauer; Penelope Hayward; Alfonso Martinez Arias
Journal:  Science       Date:  2006-12-01       Impact factor: 47.728

3.  Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi.

Authors:  Rodrigo Fernandez-Valdivia; Hideyuki Takeuchi; Amin Samarghandi; Mario Lopez; Jessica Leonardi; Robert S Haltiwanger; Hamed Jafar-Nejad
Journal:  Development       Date:  2011-04-13       Impact factor: 6.868

4.  Nonradioactive quantification of autophagic protein degradation with L-azidohomoalanine labeling.

Authors:  Jigang Wang; Jianbin Zhang; Yew Mun Lee; Shukie Ng; Yin Shi; Zi-Chun Hua; Qingsong Lin; Han-Ming Shen
Journal:  Nat Protoc       Date:  2017-01-12       Impact factor: 13.491

Review 5.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

6.  A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stability.

Authors:  Jing Fang; Qiao Meng; Peter K Vogt; Ruiwen Zhang; Bing-Hua Jiang
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

7.  Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line.

Authors:  S Xu; S Zhang; C Chen; J Yan; M Cai; X Zhu; J Gu
Journal:  J Exp Clin Cancer Res       Date:  2002-09

8.  Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.

Authors:  Huabei Guo; Tamas Nagy; Michael Pierce
Journal:  J Biol Chem       Date:  2014-10-01       Impact factor: 5.157

9.  Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1.

Authors:  Takeshi Sato; Kiyoshi Furukawa
Journal:  J Biol Chem       Date:  2004-07-19       Impact factor: 5.157

10.  Functional interaction of E1AF and Sp1 in glioma invasion.

Authors:  Jianhai Jiang; Yuanyan Wei; Jialin Shen; Dan Liu; Xiaoning Chen; Jin Zhou; Hongliang Zong; Xiaojing Yun; Xiangfei Kong; Si Zhang; Yanzhong Yang; Jianxin Gu
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

View more
  4 in total

Review 1.  The Vascular Microenvironment in Glioblastoma: A Comprehensive Review.

Authors:  Alejandra Mosteiro; Leire Pedrosa; Abel Ferrés; Diouldé Diao; Àngels Sierra; José Juan González
Journal:  Biomedicines       Date:  2022-05-31

2.  Hsc70 Interacts with β4GalT5 to Regulate the Growth of Gliomas.

Authors:  Guan Sun; Ying Cao; Xueliang Dai; Min Li; Jun Guo
Journal:  Neuromolecular Med       Date:  2019-01-03       Impact factor: 3.843

3.  Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.

Authors:  Yang Wang; Yanli Cheng; Qi Yang; Lei Kuang; Guolei Liu
Journal:  J Cell Mol Med       Date:  2022-04-14       Impact factor: 5.295

4.  Heat Shock Cognate Protein 70 Enhanced Integrin β1 Mediated Invasion in Cancer Cells.

Authors:  Guan Sun; Ying Cao; Min Li; Jun Guo; Yuyu Dai
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.